Fundraising FoxLeafy Tunnel — Full Portfolio
11 tracked investments · listed companies and verified rows first
AtaiBeckley develops rapid-acting mental health treatments and therapies for patients with difficult-to-treat mental health conditions.
BiotechDeep TechDigital HealthHealthtechMedical DevicesMental Health
Srinivas Rao(Co-Founder and Chief Executive Officer)inChristian Angermayer(Founder and Chairman of the Board)
Co-investorsAble PartnersAlpha Wave GlobalAtaiBeckleyBailey Venture PartnersCatalio Capital Management, LPFJ Labs+9 more
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsBailey Venture PartnersFJ LabsIter InvestmentsNoeticPalo Santo VCRedbus Ventures+3 more
Ceretype develops brain imaging and analysis tools that provide insights into brain circuitry for therapeutic development and clinical care of psychiatric and neurological disorders.
AI & Machine LearningBiotechDigital HealthMedical Devices
Emily Stern(CEO)inRoni Setton(Scientific Director)in
BoardDavid Silbersweig(SAB Chair)
Co-investorsJLS
IUVO is a cannabis company that partners with craft cultivators, including Organnicraft, a British Columbia-based grower of premium cannabis strains from the legacy markets of California and BC.
AgTechConsumer
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersSolari CapitalTabula Rasa VenturesWGD Capital, L.P.XEIA Venture Partners
Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.
AI & Machine LearningDigital HealthHealthtech
Co-investorsInnovating CapitalPsyMed Ventures
Prohibition Partners operates a B2B discovery platform and ecosystem for the legal cannabis industry, offering conferences, market intelligence content, digital media publishing, and a marketplace for cannabis businesses to transact products and services.
B2B MarketplacesCrypto & Web3Data & InfrastructureFintechMedia & EntertainmentLondon, GB
Stephen Murphy(Founder)in
Co-investorsArtemis Growth Partners
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)in
Co-investorsNoeticPsyMed Ventures10X CapitalPalo Santo VCWefunder
Tetra Pharm develops next-generation drugs targeting neurological disorders including chronic pain, Alzheimer's, and obesity.
BiotechDigital HealthHealthtechMedical DevicesMental HealthCopenhagen, DK
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.